g.l. zhang, a.m. khan , k.n. srinivasan, a.t. heiny, k.x. lee,

23
Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes Zhang, A.M. Khan, K.N. Srinivasan, A.T. Heiny, K.X. Lee, Kwoh, J.T. August and V. Brusic

Upload: summer-sanford

Post on 30-Dec-2015

21 views

Category:

Documents


0 download

DESCRIPTION

Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes. G.L. Zhang, A.M. Khan , K.N. Srinivasan, A.T. Heiny, K.X. Lee, C.K. Kwoh, J.T. August and V. Brusic. Outline. Background & Motivations - PowerPoint PPT Presentation

TRANSCRIPT

Hotspot Hunter: a computational system for large-scale screening and selection of candidate immunological hotspots in pathogen proteomes

G.L. Zhang, A.M. Khan, K.N. Srinivasan, A.T. Heiny, K.X. Lee,C.K. Kwoh, J.T. August and V. Brusic

22

Outline

Background & Motivations

System – Hotspot Hunter

Discussion

33

HLA

http://immuneweb.xxmc.edu.cn/Lymphoid%20System.files/UntiPCT8.jpeg

Peptide TCR

Identification of T-cell epitopes for the study of vaccines and immunotherapies

44

T-cell epitope clusters (hotspots) for the development of epitope-based vaccines

Promiscuous T-cell epitopes relevant to large proportion of the human population

Presence of clusters of promiscuous T-cell epitopes (hotspots) in antigens

H1 H4H3H2

P1P2P3P4

Promiscuous epitopes

One supertype

55

Mapping hotspots experimentally is a challenging task

Large size of pathogen proteomes (sequence length versus sequence number)

Low natural prevalence of T-cell epitopes (~1-5%) for a given HLA molecule

High cost of peptide synthesis

Limited access to human PBMC

Time-consuming experimental assays

HLA

Peptide TCR

C prM E NS1 NS2a NS2b NS3 NS4a NS4b NS5

DENV

100-900aa

>9000

C prM E NS1 NS2a NS2b NS3 NS4a NS4b NS5

DENV

100-900aa

>9000

66

Limitations of existing promiscuous epitope prediction systems

Single protein sequence per submission

Do not predict for hotspots

Impractical for large-scale systematic study of hotspots in large proteomes

Existing prediction systems are not suitable for large-scale study of hotspots

in pathogen proteomes

77

Outline

Background & Motivations

System – Hotspot Hunter

Discussion

88

http://antigen.i2r.a-star.edu.sg/hh/

99

Hotspot Hunter

Screen and select of hotspots specific to four common HLA supertypes

HLA class I A2, A3, B7 cover ~ 88% of human population

HLA class II DR cover ~100% of human population

1010

Hotspot Hunter Implementation

Predictive Engines ANN and SVM methods

Predictions results integrated using soft computing principles

10-fold cross-validation results showed that the system is of high accuracy

1111

FPFN

Hotspot Hunter can reliably identify real hotspots

30-51 95-108 118-173

30-47 130-147

Hotspot Hunter predictions

Experimental verified

HLA-DR supertype specific hotspots for HCV Core protein sequence

1212

Hotspot Hunter Functions

Single sequence query

Multiple sequence query

Target selection

Selection of common hotspot across more than one HLA supertype

1313

1414

1515Khan et al. (2006) BMC Bioinformatics

1616

1717

Outline

Background & Motivations

System – Hotspot Hunter

Discussion

1818

Allows prediction of immunological hotspots

Combines the strengths of the ANN and SVM robust prediction performance

Multiple sequence query suitable for large-scale study

Provides a utility for selecting candidate hotspots and experimental targets

Hotspot Hunter is a new generation computational tool aiding in epitope-

based vaccine design

1919

Our system can be customized and integrated into specialized databases

Tumor Antigen Database: http://research.i2r.a-star.edu.sg/Templar/DB/cancer_antigen/

CandiVF - Candida albicans Virulence Factor DatabaseTongchusak et al., (2005) Int J Pep Res Ther.

Application of Hotspot Hunter

2020

Funding Agency

NIH, USA

Acknowledgment

2121

Human pappilomavirus type 16 proteins E6 (Kast et al., 1994)

E6 hot-spot regionsHLA-A2 E6 7-34 (7-15, 18-26, and 26-34)HLA-A2 E6 52-60 (single peptide)

HLA-A3 E6 33-67 (33-41, 42-50, and 59-67) E6 75-101 (75-83, 89-97, and 93-101)

E6 125-151 (125-133 and 143-151)

Validation using experimental binders

E6HLA-A2

HLA-A3

2222

2323